Compare · MTEX vs RGC
MTEX vs RGC
Side-by-side comparison of Mannatech Incorporated (MTEX) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MTEX and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.79B, about 300.4x MTEX ($9.3M).
- Over the past year, MTEX is down 47.3% and RGC is down 61.0% - MTEX leads by 13.7 points.
PerformanceMTEX-47.31%RGC-61.02%
2025-07-30+0.00%2026-07-29
- Company
- Mannatech Incorporated
- Regencell Bioscience Holdings Limited
- Price
- $4.60-12.30%
- $5.67-5.26%
- Market cap
- $9.3M
- $2.79B
- 1M return
- -12.30%
- -9.78%
- 1Y return
- -47.31%
- -61.02%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
MTEX
Mannatech Incorporated
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through network marketing channels and a website. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Latest MTEX
- SEC Form 4 filed by Chief Financial Officer Haider Yasir
- SEC Form 3 filed by new insider Haider Yasir
- Mannatech Incorporated filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer
- SEC Form 4 filed by Director Toth Robert
- SEC Form 4 filed by Director John Seifrick A
- Mannatech Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Mannatech Announces Results of Annual Shareholders' Meeting
- Director Jobe Larry A bought $11,548 worth of shares (2,803 units at $4.12), increasing direct ownership by 4% to 70,000 units (SEC Form 4)
- Director Jobe Larry A bought $21,000 worth of shares (5,000 units at $4.20), increasing direct ownership by 8% to 67,197 units (SEC Form 4)
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited